Chong Kun Dang Bio wins patent for human insulin

Chong Kun Dang Bio announced recently that it won from Russia a patent related to a process for manufacturing a efficient human insulin precursor as the industrial scale.

Noting that 2.5 billion won was spent for the development of the item, the company added that in the formulation of manufacturing human insulin, several processes such as dissolution, sulfonated process and purification, co...